ClinicalTrials.Veeva

Menu

Effect of Ultrasound Cavitation on Insulin Resistance in Patients with Central Obesity in Female

Cairo University (CU) logo

Cairo University (CU)

Status

Enrolling

Conditions

Central Obesity

Treatments

Other: Exercise
Device: Ultrasound cavitation

Study type

Interventional

Funder types

Other

Identifiers

NCT06729203
012/005421

Details and patient eligibility

About

The purpose of this study was to investigate the effect of ultrasound cavitation on insulin resistance, HbA1c and skin fold in patients with abdominal central obesity.

Full description

Few researchers have detected the effects of ultrasonic cavitation on insulin resistance in subjects with central obesity. However, there were many conflicts and no clear evidence in the literature concerning the superiority of cavitation on body contour adjustment. Consequently, this study aimed to investigate the effects of ultrasound cavitation, aerobic exercise and a low-calorie dietary program on insulin resistance and total plasma HOMA ir and body contouring in female with abdominal obesity.

Enrollment

52 estimated patients

Sex

Female

Ages

25 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Female subjects with central obesity.
  • Female participants aged between 25 to 40 years.
  • Body Mass Index (BMI) ranged from 30 to 35 kg/m2 as high BMI indicates more obesity and central obesity.
  • Waist circumference greater than 88 cm, indicative of abdominal obesity.
  • Diagnosed with insulin resistance (HOMA-IR > 2.9).
  • Sedentary lifestyle, defined as engaging in less than 150 minutes of moderate-intensity physical activity per week.
  • Willingness to provide informed consent and comply with study procedures.

Exclusion criteria

  • • Subjects diagnosed with DM (HbA1c more than 6.5%).

    • History of metabolic disorders such as type 1 diabetes or thyroid disorders.
    • Subjects with BMI less than 30 kg/m2.
    • Subjects diagnosed with heart disease, liver as well as kidney diseases.
    • Subjects who take oral contraceptives.
    • Subjects with gestational Diabetes.
    • Pregnant or breastfeeding women were excluded from the study.
    • Use of weight-loss medications or supplements within the past six months.
    • Previous surgical procedures for weight loss or body contouring.
    • Contraindications to ultrasound therapy (e.g., metal implants in the abdomen, active skin infections).
    • Participation in another clinical trial within the last three months.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

52 participants in 2 patient groups

Group A
Experimental group
Description:
this group receive ultrasound cavitation on abdominal muscles
Treatment:
Device: Ultrasound cavitation
Group B
Active Comparator group
Description:
received aerobic exercises and low caloric diet treatment.
Treatment:
Other: Exercise

Trial contacts and locations

1

Loading...

Central trial contact

Islam Hassan Fayed, Doctorate; Aya Saeed Shazly, Master degree

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems